Kandathil A, Subramaniam RM (2017) PET/computed tomography and precision medicine: musculoskeletal sarcoma. PET Clin 12:475–488
Article
Google Scholar
Savina M, Le Cesne A, Blay JY, Ray-Coquard I, Mir O, Toulmonde M et al (2017) Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study. BMC Med. 15:78
Article
Google Scholar
Quartuccio N, Fox J, Kuk D, Wexler LH, Baldari S, Cistaro A et al (2015) Pediatric bone sarcoma: diagnostic performance of (1)(8)F-FDG PET/CT versus conventional imaging for initial staging and follow-up. AJR Am J Roentgenol. 204:153–160
Article
Google Scholar
Bakhshi S, Radhakrishnan V (2010) Prognostic markers in osteosarcoma. Expert Rev Anticancer Ther. 10:271–287
Article
Google Scholar
Treglia G, Salsano M, Stefanelli A, Mattoli MV, Giordano A, Bonomo L (2012) Diagnostic accuracy of (1)(8)F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis. Skeletal Radiol. 41:249–256
Article
Google Scholar
Tinkle CL, Weinberg V, Braunstein SE, Wustrack R, Horvai A, Jahan T et al (2015) Intraoperative radiotherapy in the management of locally recurrent extremity soft tissue sarcoma. Sarcoma. 2015:913565
Article
Google Scholar
Choi YY, Kim JY, Yang SO (2014) PET/CT in benign and malignant musculoskeletal tumors and tumor-like conditions. Semin Musculoskelet Radiol. 18:133–148
Article
Google Scholar
Benz MR, Czernin J, Allen-Auerbach MS, Tap WD, Dry SM, Elashoff D et al (2009) FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas. Clin Cancer Res. 15:2856–2863
Article
CAS
Google Scholar
Quak E, van de Luijtgaarden AC, de Geus-Oei LF, van der Graaf WT, Oyen W (2011) Clinical applications of positron emission tomography in sarcoma management. Expert Rev Anticancer Ther. 11:195–204
Article
Google Scholar
Evilevitch V, Weber WA, Tap WD, Allen-Auerbach M, Chow K, Nelson SD et al (2008) Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas. Clin Cancer Res. 14:715–720
Article
CAS
Google Scholar
Picci P, Bohling T, Bacci G, Ferrari S, Sangiorgi L, Mercuri M et al (1997) Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing’s sarcoma of the extremities. J Clin Oncol. 15:1553–1559
Article
CAS
Google Scholar
Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K et al (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 20:776–790
Article
Google Scholar
Costelloe CM, Macapinlac HA, Madewell JE, Fitzgerald NE, Mawlawi OR, Rohren EM et al (2009) 18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med. 50:340–347
Article
Google Scholar
Hawkins DS, Conrad EU 3rd, Butrynski JE, Schuetze SM, Eary JF (2009) [F-18]-fluorodeoxy-d-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults. Cancer. 115:3519–3525
Article
Google Scholar
Casey DL, Wexler LH, Fox JJ, Dharmarajan KV, Schoder H, Price AN et al (2014) Predicting outcome in patients with rhabdomyosarcoma: role of [(18)f]fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys. 90:1136–1142
Article
Google Scholar
Provisor AJ, Ettinger LJ, Nachman JB, Krailo MD, Makley JT, Yunis EJ et al (1997) Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children’s Cancer Group. J Clin Oncol. 15:76–84
Article
CAS
Google Scholar
Sheikhbahaei S, Marcus C, Hafezi-Nejad N, Taghipour M, Subramaniam RM (2015) Value of FDG PET/CT in patient management and outcome of skeletal and soft tissue sarcomas. PET Clin. 10:375–393
Article
Google Scholar
Eary JF, Conrad EU, O’Sullivan J, Hawkins DS, Schuetze SM, O’Sullivan F (2014) Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome. J Bone Joint Surg Am. 96:152–158
Article
Google Scholar
Arndt CA, Rose PS, Folpe AL, Laack NN (2012) Common musculoskeletal tumors of childhood and adolescence. Mayo Clin Proc. 87:475–487
Article
Google Scholar
Qin Z, Tang Y, Wang H, Cai W, Fu H, Li J et al (2015) Use of 18F-FDG-PET-CT for assessment of response to neoadjuvant chemotherapy in children with Wilms tumor. J Pediatr Hematol Oncol. 37:396–401
Article
CAS
Google Scholar
Denecke T, Hundsdorfer P, Misch D, Steffen IG, Schonberger S, Furth C et al (2010) Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters. Eur J Nucl Med Mol Imaging. 37:1842–1853
Article
Google Scholar
Angelini A, Ceci F, Castellucci P, Graziani T, Polverari G, Trovarelli G et al (2017) The role of (18)F-FDG PET/CT in the detection of osteosarcoma recurrence. Eur J Nucl Med Mol Imaging. 44:1712–1720
Article
Google Scholar
Iagaru A, Masamed R, Chawla SP, Menendez LR, Fedenko A, Conti PS (2008) F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas. Clin Nucl Med. 33:8–13
Article
Google Scholar
Eilber FC, Rosen G, Eckardt J, Forscher C, Nelson SD, Selch M et al (2001) Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol. 19:3203–3209
Article
CAS
Google Scholar
Bastiaannet E, Groen H, Jager PL, Cobben DC, van der Graaf WT, Vaalburg W et al (2004) The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas: a systematic review and meta-analysis. Cancer Treat Rev. 30:83–101
Article
CAS
Google Scholar
Schaefer NG, Taverna C, Strobel K, Wastl C, Kurrer M, Hany TF (2007) Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed? Radiology. 244:257–262
Article
Google Scholar
Charest M, Hickeson M, Lisbona R, Novales-Diaz JA, Derbekyan V, Turcotte RE (2009) FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases. Eur J Nucl Med Mol Imaging. 36:1944–1951
Article
Google Scholar
Hawkins DS, Rajendran JG, Conrad EU 3rd, Bruckner JD, Eary JF (2002) Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-d-glucose positron emission tomography. Cancer. 94:3277–3284
Article
CAS
Google Scholar
Kumar R, Chauhan A, Vellimana AK, Chawla M (2006) Role of PET/PET–CT in the management of sarcomas. Expert Rev Anticancer Ther 6:1241–1250
Article
Google Scholar
Rosen G, Caparros B, Groshen S, Nirenberg A, Cacavio A, Marcove RC et al (1984) Primary osteogenic sarcoma of the femur: a model for the use of preoperative chemotherapy in high risk malignant tumors. Cancer Invest. 2:181–192
Article
CAS
Google Scholar
Picci P, Rougraff BT, Bacci G, Neff JR, Sangiorgi L, Cazzola A et al (1993) Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing’s sarcoma of the extremities. J Clin Oncol. 11:1763–1769
Article
CAS
Google Scholar
Murphy WA Jr (1991) Imaging bone tumors in the 1990s. Cancer. 67:1169–1176
Article
Google Scholar
McCarville MB, Christie R, Daw NC, Spunt SL, SCJAJoR K (2005) PET/CT in the evaluation of childhood sarcomas. AJR Am J Roentgenol 184:1293–1304
Article
Google Scholar
Bredella MA, Caputo GR, Steinbach LS (2002) Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas. AJR Am J Roentgenol. 179:1145–1150
Article
Google Scholar